BioSpace News Archive

NEW YORK , Feb. 20, 2020 /PRNewswire/ -- Kallyope Inc ., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis, today announced that Peter Hecht , Ph.D., CEO of Cyclerion Therapeutics, has been appointed to the company’s Board of Directors. Prior to joining Cyclerio

LAUSANNE , Switzerland and BOSTON , Feb. 20, 2020 /PRNewswire/ -- SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020 . He is replacing Antoine Duchateau , who has served as chairman since 2013 and will continue as a board member. Cox j

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that China has issued Chinese Patent CN106456573B (the “Patent”)

SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that regulatory clearances have been issued with respect to four products Merit owns or holds the rights to distribute. Merit received clearance from the China National Medical Products Association (NMPA) to market the Swift Ninja™ Steerable Microcatheter i

Wize acquires $2.5 million worth of Bonus BioGroup through minority ownership stake in Bonus BioGroup

Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company’s CE-marked Peregrine System™ Infusion Catheter were published in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018 More than tripled total contract order volume received year-over-year to about EUR 3.4 million 2019 Combined revenue for both companies (had the business combination taken place at the start of 2019) would have been approximately $6 million, a 31% increase from the prior year GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) reported an update on the business of Curetis GmbH (“Curet

The Genesys Spine Sacroiliac Joint Fusion System consists of partially threaded and fully threaded implants designed to secure the sacroiliac joint and minimize micro-motion enabling bony fusion.

We aim to inspire future generations of nurses by celebrating and highlighting the leadership, innovation and dedication of our nurse volunteers throughout the year

Newport Academy, a series of leading adolescent and young adult treatment centers specializing in mental health, trauma, and other psychiatric diagnoses, has announced the spring line-up for its Newport Healthcare Day Conferences.